Business Standard

Moderna to ask US, European regulators to OK its vaccine for emergency use

The company is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the US in December.

Moderna
Premium

Representational image of the Covid-19 vaccine developed by US drugmaker Moderna

AP | PTI
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.

Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the U.S. and Europe. U.S. hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day and more than 1,400 daily deaths. Since first emerging nearly a year ago

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 30 2020 | 5:38 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com